Structural changes in cerebral arteries following nitric oxide deprivation: A comparison between normotensive and hypertensive rats

Thrombosis and Haemostasis

Volumn 92, Issue 1, 2004, Pages 162-170

  Hsieh, Nan K ^a   Wang, Jia Y ^a   Liu, Jiang C ^a   Lee, Wei H ^a   Chen, Hsing I ^b  

^a NATIONAL DEFENSE UNIVERSITY   (Taiwan)

^b TZU CHI UNIVERSITY   (Taiwan)

Author keywords

Hypertension; Inflammatory cell; Nitric oxide blockade; Stroke; Vascular remodelling

Indexed keywords

N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOLE; ARTERY BLOOD FLOW; ARTERY DIAMETER; ARTERY MEDIA; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY WEIGHT; BRAIN ARTERY; CELL DENSITY; CELL VOLUME; CHRONIC DISEASE; CONTROLLED STUDY; GROWTH CURVE; HEART WEIGHT; HEREDITARY HYPERTENSION; IMMUNOHISTOCHEMISTRY; INFLAMMATORY INFILTRATE; INTERNAL CAROTID ARTERY; MALE; MORPHOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; SCORING SYSTEM; SPONTANEOUSLY HYPERTENSIVE RAT; STRAIN DIFFERENCE; TAIL; TISSUE INJURY;

EID: 3543041259     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/th03-10-0610     Document Type: Article

References (42)

1. O'Donell CJ, Ridker PM, Glynn RJ, et al. Hypertension and borderline isolated systolic hypertension increase risks of cardiovascular disease and mortality in male physicians. Circulation 1997; 95: 1132-7.
2. Hansson L, Zanchetti A, Carruthers SG, et al. for the HOT Study Group. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the hypertension optimal treatment (HOT) randomised trial. Lancet 1998; 351: 1755-62.
3. Pockley AG. Heat shock proteins, inflammation, and cardiovascular disease. Circulation 2002; 105: 1012-7.
4. Dahlof B, Lindholm LH, Hansson L, et al. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet 1991; 338: 1281-5.
5. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991; 43: 109-42.
6. Mulvany MJ. Resistance vessels in hypertension. In: Swales JD, Eds. Textbook of Hypertension. Oxford: Blackwell Scientific Publications, 1994: 103-19.
7. Loscalzo J. Nitric oxide and vascular disease. N Engl J Med 1995; 333: 251-3.
8. Ribeiro MO, Antunes E, Nucci G, et al. Chronic inhibition of nitric oxide synthesis: A new model of arterial hypertension. Hypertension 1992; 20: 298-303.
9. Chu Y, Heistad DD, Kathryn K, et al. Quantification of Mrna for endothelial NO synthase in mouse blood vessels by real-time polymerase chain reaction. Arterioscl Thromb Vasc Biol 2002; 22: 611-6.
10. Ignarro LJ, Napoli C, Loscalzo J. Nitric oxide donors and cardiovascular agents modulating the bioactivity of nitric oxide: An overview. Circ Res 2002; 90: 21-8.
11. Zhao Q, Egashira K, Inoue S, et al. Vascular endothelial growth factor is necessary in the development of arteriosclerosis by recruiting/activating monocytes in a rat model of long-term inhibition of nitric oxide synthesis. Circulation 2002; 105: 1110-5.
12. Baumbach GL, Dobrin PB, Hart MN, et al. Mechanics of cerebral arterioles in hypertensive rats. Circ Res 1988; 62: 56-64.
13. Mulvany MJ, Aalkjær C. Structure and function of small arteries. Physiol Rev 1990;70: 921-61.
14. Bund SJ, West KP, Heagerty AM. Effects of protection from pressure on resistance artery morphology and reactivity in spontaneously hypertensive and Wistar-Kyoto rats. Circ Res 1991; 68: 1230-40.
15. Wang JY, Fenstermacher JD, Shum AY. Regional variations in structural and functional adaptations in cerebral vasculature in chronic hypertension. J Med Sci 1991; 11: 79-100.
16. Moncada S, Higgs EA, The L-arginine-nitric oxide pathway. N Eng J Med 1993; 329: 2002-13.
17. Hajdu MA, Baumbach G. Mechanics of large and small cerebral arteries in chronic hypertension. Am J Physiol 1994; 266: H1027-H1033.
18. Mulvany MJ, Baumbach GL, Aalkjaer C, et al. Vascular remodeling. Hypertension 1996; 28: 505-6.
19. Viedt C, Vogel J, Athanasiou T, et al. Monocyte chemoattractant protein induces proliferation and interleukin-6 production in human smooth muscle cells by differential activation of nuclear factor-κB and activator protein-1. Arterioscl Thromb Vasc Biol 2002; 22: 914-20.
20. Chen HI, Hu CT. Endogenous nitric oxide on arterial hemodynamics: a comparison between normotensive and hypertensive rats. Am J Physiol 1997; 273: H1816-H1823.
21. Schiffrin EL, Park JB, Intengan HD, Touys T. Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan. Circulation 2000; 101: 1653-9.
22. Bots ML, Hoes AW, Koudstaal PJ, et al. Common carotid indima-media thickness and risk of stroke and myocardial infarction: the Rotterdam study. Circulation 1997; 96: 1432-7.
23. Ward MR, Pasterkamp G, Yeung AC, et al. Arterial remodeling: mechanisms and clinical implications. Circulation 2000; 102: 1186-91.
24. Dijkstra CD, Dopp EA, Joling P, et al. The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1,ED2,and ED3. Immunology 1985; 54: 589-99.
25. Bendeck MP. Mining the myocardium with macrophage drills, a novel mechanism for revascularization. Circ Res 2000; 87: 341-3.
26. Mai M, Geiger H, Hilgers KF, et al. Early interstitial changes in hypertension-induced renal injury. Hypertension 1993; 22: 754-65.
27. Ono H, Ono Y, Frohlich ED. Nitric oxide synthase inhibition in spontaneously hypertensive rats: systemic, renal, and glomerular hemodynamics. Hypertension 1995; 26: 249-55.
28. Arnal JF, Amrani AIE, Chatellier G, et al. Cardiac weight in hypertension induced by nitric oxide synthase blockade. Hypertension. 1993; 22: 380-7.
29. Sigmon DH, Carretero OA, Beierwaltes WH. Endothelium-derived relaxing factor regulates renin release in vivo. Am J Physiol 1992; 263: 256-61.
30. Alberola A, Pinilla JM, Quesada T, et al. Role of nitric oxide in mediating renal response to volume expansion. Hypertension 1992; 19: 780-4.
31. Raij L. Nitric oxide in hypertension: relationship with renal injury and left ventricular hypertrophy. Hypertension 1998; 31: 189-93.
32. Roman Mj, Saba PS, Pini R, et al. Parallel cardiac and vascular adaptation in hypertension. Circulation 1992; 86: 1909-18.
33. Godin D, Ivan E, Johnson C, et al. Remodeling of carotid artery is associated with increased expression of matrix metalloproteinases in mouse blood flow cessation model. Circulation 2000; 102: 2861-6.
34. Schiffrin EL. Effect of antihypertensive therapy on small artery structure in hypertensive patients. Hypertension 1995; 26: 716-7.
35. Koyanagi M, Egashira K, Kitamoto S, et al. Role of monocyte chemoattractant protein-1 in cardiovascular remodeling induced by chronic blockade of nitric oxide synthesis. Circulation 2000; 102: 2243-8.
36. McDonald DM, Munn L, Jain RK. Vasculogenic mimicry: how convincing, how novel, and how significant? Am J Pathol 2000; 156: 383-7.
37. Moldovan NI, Goldschmidt-Clermont PJ, Parker-Thornburg J, et al. Contribution of monocytes/macrophages to compensatory neovascularization: the drilling of metalloelastase-positive tunnels in ischemic myocardium. Circ Res 2000; 87: 378-84.
38. Yang ZY, Duckers HJ, Sullivan NJ, et al. Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury. Nat Med 2000; 6: 886-90.
39. Langille BL. Arterial remodeling: relation to hemodynamics. Can J Physiol Pharmacol 1996; 74: 834-41.
40. Diep QN, Mabrouk ME, Cohn JS, et al. Structure, endothelial function, cell growth, and inflammation in blood vessels of angiotensin II-infused rats: Role of peroxisome proliferator-activated receptor-γ. Circulation 2002; 105: 2296-302.
41. Lowe G, Rumley A, Norric J, et al. WOSKOPS. Blood rheology, cardiovascular risk factors and cardiovascular disease: The West of Scotland Coronary Prevention Study. Thromb Haemost 2000; 84: 553-8.
42. Niu X, Smith CW, Kubes P. Intracellular oxidative stress induced by nitric oxide synthesis inhibition increases endothelial cell adhesion to neutrophils. Circ Res 1994; 74: 1133-40.